Trial Profile
Retrospective single-centre study investigating impact of prophylaxis with posaconazole and levofloxacin in acute myeloid leukemia patients undergoing intensive chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Levofloxacin (Primary) ; Posaconazole (Primary) ; Amphotericin B; Cefepime; Dexamethasone; Piperacillin/tazobactam; Sulfamethoxazole; Trimethoprim
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 12 Dec 2015 New trial record